Robert Stanley Sheldon, BSc, MD, PhD, FRCP(C)

Professor, Department of Medicine

Faculty of Medicine, University of Calgary 

Tel: (403) 220-8191

 

Publications

Luethi M, Roach DE, Beaudin AE, Debert CT, Sheldon RS, Poulin M. Effects of hypoxia and hypercapnia on respiratory sinus arrhythmia in women. Clin Auton Res 2008, 18:134-144.

Veenhuyzen George D, Coverett Kelly O, Quinn F. Russell, Sapp John, Gillis Anne. M, Sheldon RS, Cassidy Margaret R, Mardell Andrew, Exner Derek. V, Mitchell L. Brent. One diagnostic maneuver to guide catheter ablation of sustained supraventricular tachycardia. Heart Rhythm 2008; 5:1152-8.

Gillis AM, Morck M, Exner DV, Soo A, Sarah Rose M, Sheldon RS, Duff HJ, Kavanagh KM, Brent Mitchell L, George Wyse D. Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation. Eur Heart J. 2008 Aug;29(15):1873-80

J. Gert van Dijk, Robert Sheldon. Is there any point to vasovagal syncope? Clin Auton Res (2008) 18:167-169. (Invited, reviewed editorial).

Kuriachan V, Sheldon R, Platonov M. Evidence-based treatment for vasovagal syncope. Heart Rhythm 2008, 5:1609-14.

Anna Serletis Bizios MD and Robert S Sheldon. Vasovagal syncope: State or Trait? Curr Opin Cardiol 2008, 24:68-73.

Tang AS, Wells GA, Arnold M, Connolly S, Hohnloser S, Nichol G, Rouleau J, Sheldon R, Talajic M. Resynchronization/defibrillation for Ambulatory heart Failure Trial (RAFT): rationale and trial design. Curr Opin Cardiol 2008, 24:1-8.

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Amadeus Investigators, Bousser MG, Bouthier J, Büller HR, Cohen AT, Crijns H, Davidson BL, Halperin J, Hankey G, Levy S, Pengo V, Prandoni P, Prins MH, Tomkowski W, Thorp-Pedersen C, Wyse DG. Lancet. 2008 Jan 26;371(9609):315-21.

Gillis AM, Morck M, Exner DV, Sheldon RS, Duff HJ, Mitchell LB, Wyse DG. Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long term follow-u p. Europace 2009; 11: 1041-1047

Rose MS, Ritchie D, Koshman ML, Sheldon R. The Development and Preliminary Validation of a Scale Measuring the Impact of Syncope on Quality of Life. Europace 2009; 11: 1369-1374.

Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn AD, Sheldon A, Koshman ML, Ritchie D, for the Investigators of the Prevention of Syncope Study. DESIGN AND USE OF A QUANTITATIVE SCALE FOR MEASURING PRESYNCOPE. J Cardiovasc Electrophysiol 2009; 20: 888-893.

Moya A, Sutton R et al. European Society of Cardiology guidelines for the assessment and management of syncope - 2009. Eur Heart J 2009; 30: 2631-2671.

The ACTIVE Investigators. Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation. N Engl J Med 2009;360. (10.1056/NEJMoa0901301)

Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn AD, Koshman ML, Ritchie D, for the Investigators of the Prevention of Syncope Study. Effect of metoprolol on quality of life in the Prevention of Syncope Trial. J Cardiovasc Electrophysiol 2009, 20:1083-1088.

 

Research Funding

“Prevention of Syncope Trial II” 2004-20011, CIHR

SIRCAT: STATIN-INDUCED REGRESSION OF CARDIOMYOPATHY TRIAL” HSFA 2006-2010